Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Federal Court Denies IVC Lawsuit Plaintiffs’ Request for Bard Foreign Communications

The federal court overseeing hundreds of IVC filter lawsuits filed against C.R. Bard, Inc. has ruled that the company will not have to produce electronically stored foreign communications during discovery. According to a report from Bloomberg BNA, plaintiffs were seeking … Continue reading

Bair Hugger Lawsuit Plaintiffs Discuss Their Ordeals

Two Texans who are pursuing Bair Hugger lawsuits against the 3M Company and Arizant Healthcae, Inc. recently came forward to discuss their experiences with a Houston media outlet. Both plaintiffs are alleged to have developed deep joint infections after the … Continue reading

Invokana Lawsuit Plaintiffs Seek Centralization of Federal Injury Claims

Plaintiffs who have filed Invokana lawsuits over ketoacidosis, kidney injuries and heart attacks are seeking to have their claims centralized in a single federal court. In a Motion for Transfer filed with the U.S. Judicial Panel on Multidistrict Litigation on … Continue reading

Study Points to Possible Physiomesh Hernia Recurrence Risk

A recent study suggests that patients who receive Ethicon, Inc.’s Physiomesh Flexible Composite Mesh device during minimally-invasive ventral hernia repair may face a higher risk of recurrence compared to those implanted with an alternative hernia patch. The study was published … Continue reading

Another Study Links Proton Pump Inhibitors to Chronic Kidney Disease

Yet another study has suggested that individuals who use proton pump inhibitors may be more likely to develop chronic kidney disease. The authors of the paper, which was published last month in BMC Nephrology, also surmised that the increased risk … Continue reading

New Jersey Woman Claims Nexium Caused Kidney Failure

The growing litigation involving Nexium and serious kidney complications shows no signs of slowing down. Just this week, a new case was filed in New Jersey federal court on behalf of a woman who developed kidney failure, allegedly due to … Continue reading

Taxotere Hair Loss Litigation Grows, as Federal Filings Surpass 50

More than 50 Taxotere lawsuits have been filed in federal courts on behalf of cancer patients who allegedly experienced permanent alopecia due to treatment with the chemotherapy agent. The number of such cases has nearly doubled since July, when just … Continue reading

Pennsylvania Woman Claims Inadequate Avelox Warnings Responsible for Peripheral Neuropathy

A Pennsylvania woman has filed a lawsuit against the manufacturers of Avelox, alleging that the lack of adequate safety warnings was responsible for her peripheral neuropathy diagnosis. Court records indicate that the Avelox lawsuit was initially filed in the U.S. … Continue reading

Abuse of Concerta, Other ADHD Drugs A Growing Problem

A new report suggests that public health officials may be ignoring a new prescription drug scourge – the abuse of Concerta and other ADHD medications by adults. According to a joint investigation conducted by the Milwaukee Journal-Sentinel and MedPage Today, … Continue reading

Vascu-Guard Patch Recall Latest in String of Issues for Baxter International

It was a rough summer for Baxter International, Inc., which was forced to issue its second recall for the Vascu-Guard Peripheral Vascular Patch. Unfortunately, it appears that the Vascu-Guard Patch recall was only the latest safety issue to ensnare the … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content